Tranexamic Acid
25 NDCs across 20 manufacturers|25 Generic,0 Brand
Tranexamic Acid is used to treat inherited blood coagulation disorders and subarachnoid hemorrhage, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Dec 30, 1986, and the first generic was approved Aug 10, 2011. FDA's Orange Book lists 7 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $3 million on Tranexamic Acid across 62,000 claims for 44,000 beneficiaries.
Tranexamic Acid is available as 25 NDCs from 20 manufacturers (25 generic, 0 brand), with NADAC prices from $0.35 to $0.40 per ML — a 16% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
25
25G / 0B
Manufacturers
20
competing in market
Price Spread
$0.35 – $0.40
per ML, 17 of 25 NDCs
7d Activity
avg +1.9% WoW · of 25 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Heritage Pharmaceuticals Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Antifibrinolytic Agent class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
20 manufacturers producing TRANEXAMIC ACID
Frequently Asked Questions
What is Tranexamic Acid used to treat?
Tranexamic Acid is used to treat inherited blood coagulation disorders and subarachnoid hemorrhage, per the National Library of Medicine's MED-RT classification.
When did Tranexamic Acid become available as a generic?
FDA approved the first generic Tranexamic Acid (ANDA) on Aug 10, 2011. The Orange Book currently lists 7 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Tranexamic Acid?
In 2024, Medicare Part D spent $3 million on Tranexamic Acid across 62,000 claims for 44,000 beneficiaries.
How many Tranexamic Acid products are on the market?
The Tranexamic Acid drug market contains 25 NDCs from 20 manufacturers — 25 generic and 0 brand products.
What is the price range for Tranexamic Acid?
NADAC reference prices for Tranexamic Acid range from $0.3481 to $0.4035 per ML — a 16% difference between cheapest and most expensive. 8 additional products are priced per different units (e.g. liquids per ML) and aren't directly comparable.
Which manufacturers make Tranexamic Acid?
20 manufacturers list Tranexamic Acid in NADAC. Ranked by number of NDCs, the largest are Heritage Pharmaceuticals Inc. (3), Sagent Pharmaceuticals (2), Provepharm Inc. (2), Armas Pharmaceuticals Inc. (2), Actavis Pharma, Inc. (1).
How has the price of Tranexamic Acid changed recently?
Over the past 7 days, 15 Tranexamic Acid NDCs rose and 8 fell, with a market-wide average change of +1.9%.